GMED
Price
$59.09
Change
+$0.44 (+0.75%)
Updated
Aug 11, 03:03 PM (EDT)
Capitalization
7.92B
92 days until earnings call
WRBY
Price
$23.23
Change
-$0.10 (-0.43%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
2.85B
87 days until earnings call
Interact to see
Advertisement

GMED vs WRBY

Header iconGMED vs WRBY Comparison
Open Charts GMED vs WRBYBanner chart's image
Globus Medical
Price$59.09
Change+$0.44 (+0.75%)
Volume$200
Capitalization7.92B
Warby Parker
Price$23.23
Change-$0.10 (-0.43%)
Volume$17.35K
Capitalization2.85B
GMED vs WRBY Comparison Chart in %
Loading...
GMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WRBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GMED vs. WRBY commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMED is a Hold and WRBY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (GMED: $58.65 vs. WRBY: $23.33)
Brand notoriety: GMED and WRBY are both not notable
GMED represents the Medical/Nursing Services, while WRBY is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: GMED: 251% vs. WRBY: 141%
Market capitalization -- GMED: $7.92B vs. WRBY: $2.85B
GMED [@Medical/Nursing Services] is valued at $7.92B. WRBY’s [@Pharmaceuticals: Other] market capitalization is $2.85B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $233.71B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $168.51B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.52B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GMED’s FA Score shows that 0 FA rating(s) are green whileWRBY’s FA Score has 0 green FA rating(s).

  • GMED’s FA Score: 0 green, 5 red.
  • WRBY’s FA Score: 0 green, 5 red.
According to our system of comparison, WRBY is a better buy in the long-term than GMED.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GMED’s TA Score shows that 6 TA indicator(s) are bullish while WRBY’s TA Score has 3 bullish TA indicator(s).

  • GMED’s TA Score: 6 bullish, 3 bearish.
  • WRBY’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, GMED is a better buy in the short-term than WRBY.

Price Growth

GMED (@Medical/Nursing Services) experienced а +11.42% price change this week, while WRBY (@Pharmaceuticals: Other) price change was -1.14% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.03%. For the same industry, the average monthly price growth was +0.41%, and the average quarterly price growth was +3.73%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.86%. For the same industry, the average monthly price growth was -3.35%, and the average quarterly price growth was +2.88%.

Reported Earning Dates

GMED is expected to report earnings on Nov 11, 2025.

WRBY is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Medical/Nursing Services (-2.03% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (+1.86% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GMED($7.92B) has a higher market cap than WRBY($2.85B). WRBY YTD gains are higher at: -3.635 vs. GMED (-29.090). GMED has higher annual earnings (EBITDA): 553M vs. WRBY (24.9M). GMED has more cash in the bank: 461M vs. WRBY (265M). GMED has less debt than WRBY: GMED (92.3M) vs WRBY (224M). GMED has higher revenues than WRBY: GMED (2.51B) vs WRBY (795M).
GMEDWRBYGMED / WRBY
Capitalization7.92B2.85B278%
EBITDA553M24.9M2,221%
Gain YTD-29.090-3.635800%
P/E Ratio22.73N/A-
Revenue2.51B795M316%
Total Cash461M265M174%
Total Debt92.3M224M41%
FUNDAMENTALS RATINGS
GMED: Fundamental Ratings
GMED
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
74
SMR RATING
1..100
85
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GMEDWRBY
RSI
ODDS (%)
Bullish Trend 4 days ago
73%
Bearish Trend 4 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
72%
Bearish Trend 4 days ago
79%
Momentum
ODDS (%)
Bullish Trend 4 days ago
65%
Bearish Trend 4 days ago
73%
MACD
ODDS (%)
Bullish Trend 4 days ago
67%
Bearish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
65%
Bearish Trend 4 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
64%
Bullish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
65%
Bullish Trend 21 days ago
85%
Declines
ODDS (%)
Bearish Trend 12 days ago
58%
Bearish Trend 4 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
63%
Bearish Trend 4 days ago
68%
Aroon
ODDS (%)
Bearish Trend 4 days ago
60%
Bullish Trend 4 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
GMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WRBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RXI191.840.79
+0.41%
iShares Global Consumer Discr ETF
QCJA21.030.08
+0.39%
FT Vest Nasdaq-100 Cnsrv Buffr ETF - Jan
AGNG31.930.06
+0.18%
Global X Aging Population ETF
SOLR28.68N/A
N/A
SmartETFs Sustainable Energy II ETF
RWO44.28-0.07
-0.16%
SPDR® Dow Jones® Global Real Estate ETF

GMED and

Correlation & Price change

A.I.dvisor indicates that over the last year, GMED has been loosely correlated with VREX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if GMED jumps, then VREX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GMED
1D Price
Change %
GMED100%
+8.47%
VREX - GMED
49%
Loosely correlated
+21.38%
CTKB - GMED
48%
Loosely correlated
-1.95%
CVRX - GMED
47%
Loosely correlated
+4.32%
ILMN - GMED
43%
Loosely correlated
-0.98%
A - GMED
41%
Loosely correlated
+0.56%
More

WRBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, WRBY has been loosely correlated with STE. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if WRBY jumps, then STE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WRBY
1D Price
Change %
WRBY100%
-0.64%
STE - WRBY
45%
Loosely correlated
+2.80%
TWST - WRBY
39%
Loosely correlated
+2.56%
ARAY - WRBY
36%
Loosely correlated
+5.30%
GKOS - WRBY
35%
Loosely correlated
-3.81%
GMED - WRBY
34%
Loosely correlated
+8.47%
More